India To Add HIV/AIDS, TB Drugs To List Of Medicines Subject To Price Caps, Sources Say

Reuters: India to add more AIDS, TB drugs to essential medicines list: sources
“India is likely to add more HIV/AIDS and tuberculosis drugs to its list of essential medicines that are subject to price caps, people directly involved in the process said, in a move to improve affordability of drugs to treat the deadly diseases…” (Siddiqui, 4/2).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.